Call MEDISCA now at 1-800-932-10391300 786 392

Personalised Analgesic Therapy:

Targeting Pain at Its Source

Target Audience

Pharmacists, pharmacy technicians, physicians, nurse practitioners, and other healthcare providers looking to get into or are currently engaged in pain management.


Live Virtual Seminar (4 days x 4 hours) that allows you to connect online, in real time, with healthcare providers across the globe. Interact with peers and facilitators through open mic Q&A sessions, group discussions, polls, and online chats. Practically apply your knowledge through case assessments & formula investigations. Leave the live event with a comprehensive manual containing references, charts, and tools that will assist with expanding your practice and optimizing therapeutic outcomes for you patients.


Chronic pain is the primary reason patients seek healthcare, affecting more than 1.5 billion people worldwide, and, despite advances in pain research and knowledge, pain remains inadequately treated. Challenges in current pain management can be described by:

  1. Adverse systemic side effects, including GI ulcers, liver toxicity, CNS effects, and opioid use disorder
  2. Inadequate therapeutic efficacy (30-50% of individuals with chronic pain report pain is not adequately controlled)
  3. Poor patient compliance resulting from adverse side effects and inadequate therapeutic outcomes
  4. The need for greater understanding by the medical community on how to appropriately target pain pathways
  5. The overarching objective of this program is to address the 4 major challenges described above:
    • Reduce systemic adverse events through topical and local analgesic applications
    • Optimise therapeutic outcomes by carefully targeting pain at its source, selecting appropriate analgesics based on pharmacodynamics, and applying appropriate combination therapy
    • Improve patient compliance by reducing adverse events, improving outcomes, and simplifying treatment regimens
    • Provide healthcare providers the tools to appropriately assess and classify pain, identify anatomical structures and pathways, and appropriately utilise analgesics based on pharmacodynamics, safety, and efficacy profiles – ultimately reducing adverse events, improving outcomes, and reducing opioid use

At this 2-day event, day 1 will be dedicated to laying the foundations for an alternative and improved approach to pain management by reviewing pain physiology (types of pain, pain pathways & neural systems, and sensitisation), analgesic pharmacology of 50+ ingredients (pharmacodynamics, efficacy, safety, and dosing), and topical therapy applications (skin physiology, delivery systems, and formulation considerations). The skills and knowledge that is acquired from day 1 will be put to work on day 2 with patient case assessments and formula investigations for common pain or pain-related conditions, including osteoarthritis, low back pain, diabetic neuropathy, anal fissures, fibromyalgia, surgical pain, and opioid use disorder.

Learning Objectives

  1. Identify challenges in pain management including adverse systemic reactions, inadequate therapeutic outcomes, poor patient compliance, and the need for education in pain management.
  2. Classify different types of pain, notably nociceptive pain, neuropathic pain, functional pain, and mixed pain.
  3. Investigate the neural systems and sensitization processes involved at each level of the pain pathway, including the periphery, the dorsal horn, the ascending pathway, the brain, and the descending pathway.
  4. Evaluate and organize current evidence on analgesic pharmacology with special focus on pharmacodynamics, efficacy, safety, and dosing of over 50 analgesics.
  5. Utilise fundamental concepts of topical therapy, including skin anatomy (target layers), physiology (lipids, hydration, temperature, pH, metabolism, and microbiome), individual differences (age, ethnicity, and sensitivities), and formulation consideration (delivery systems, premade base concepts, penetration enhancers, among more).
  6. Apply skills and knowledge in the form of case assessments and formula investigations for common pain or pain-related conditions.


Miguel De La Garza, MD, DABA, DAPM

Dr. de la Garza is a board certified physician who practices multidisciplinary interventional pain management in four offices in the Tampa Bay area. He performs interventional pain procedures, specializing in minimally invasive surgical decompression of herniated discs and spinal stenosis, implantable intrathecal pumps, spinal cord stimulation, and peripheral nerve stimulation. Dr. de la Garza has published numerous research papers and abstracts, and has presented at regional and national academic conferences on the topics of anesthesia and pain medicine. He is also a consultant for numerous pharmaceutical and medical device manufacturers.

Dr. de la Garza received a Bachelor of Science in Molecular Biology and a Bachelor of Arts in Chemistry from Texas Lutheran College in Seguin, Texas. He graduated from the University of Texas Southwestern Medical School in 2001 and performed his anesthesia residency at the University of South Florida College of Medicine, Department of Anesthesiology and Critical Care from 2001 to 2005. He then completed an interventional pain medicine fellowship at The Cleveland Clinic, in the Department of Anesthesia and Pain Management.

Ken Speidel, BS Pharm, PharmD, RPh, FIACP, FACA

Dr. Ken Speidel is well recognized for his broad experience in pharmacy practice and education with pharmacotherapeutic specialties in hormone therapy and pain management. Dr. Speidel is a leading subject-matter expert in pharmaceutical compounding with expertise in sterile and non-sterile compounding processes for the acute care, community, outpatient, and 503A/503B practice sectors. Dr. Speidel has played instrumental roles in the development of national standards for pharmacy compounding practices and provides consulting services to many organizations, including boards of pharmacy and hospital and health systems in the United States and abroad.

In addition to his worldwide consulting and educational work, Dr. Speidel is a retired Professor of Pharmacy Practice from the University of Findlay. Over the years, Dr. Speidel has assisted in the development and facilitation of many nationally recognized educational programs, approved by the Accreditation Council for Pharmacy Education (ACPE). Dr. Speidel served as senior surveyor and advisor for the development of the Pharmacy Compounding Accreditation Board (PCAB). Dr. Speidel has served as multi-term president of the National Home Infusion Association (NHIA), president of Hospice of Portage, and has been awarded fellowship status with the Alliance for Pharmacy Compounding (APC) and the American College of Apothecaries (ACA). Dr. Speidel received a Bachelor of Science and Doctor of Pharmacy from Ohio Northern University and has completed postdoctoral training in nutritional support and functional medicine.

Dr. Speidel is best known for his charismatic charm, his endless book of analogies, and ability to get everyone in the room motivated and passionate about personalized healthcare!


This activity may eligible for Pharmacist and Physician accreditation. Please see final activity description for details.

Completion Requirements

Attend in full, complete learning assessments, and complete the activity evaluation.


Activity material is Copyright© LP3 Network Inc. 2020-2021.

Declarations and Disclosures

This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network assist with the marketing of this activity. LP3 Network is an independent corporation. LP3 Network has an established agreement with MEDISCA Australia ensuring that it has no influence on LP3 Network as it relates to activity offerings.

Financial Support

This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.

Cancellation and Refund Policy

In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation.In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date.This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.

Transfer Policy – Australia Courses Only

This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.


We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.

Copyright® 1989-2021 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified